Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under...
154 KB (13,880 words) - 13:52, 20 April 2024
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
318 KB (19,351 words) - 20:00, 21 April 2024
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
192 KB (22,024 words) - 10:32, 9 May 2024
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023[update], India has administered over 2.2 billion doses overall...
181 KB (11,351 words) - 20:37, 16 May 2024
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
213 KB (16,972 words) - 00:44, 9 May 2024
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,...
142 KB (11,316 words) - 14:22, 4 February 2024
an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration...
122 KB (11,028 words) - 02:32, 27 January 2024
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
236 KB (19,398 words) - 05:58, 20 April 2024
authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna...
126 KB (9,742 words) - 20:45, 16 May 2024
Sputnik Light (Russian: Спутник Лайт, romanized: Sputnik Layt or Lajt) is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of...
11 KB (1,034 words) - 02:09, 27 September 2023
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
90 KB (8,570 words) - 16:40, 27 January 2024
AWcorna, originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen...
14 KB (1,441 words) - 21:06, 14 October 2023
10 million doses of COVID-19 Janssen vaccine; 5 million doses of COVID-19 vaccine Pfizer; 10 million doses of COVID-19 vaccine Sputnik V. Currently, the parties...
112 KB (8,532 words) - 04:36, 9 February 2024
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine...
18 KB (1,385 words) - 20:42, 22 January 2024
COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021. The Oxford–AstraZeneca vaccine was the only COVID-19 vaccine authorized...
53 KB (3,591 words) - 20:15, 16 May 2024
Covaxin (category Indian COVID-19 vaccines)
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council...
41 KB (3,838 words) - 13:07, 22 March 2024
to produce Russia's Sputnik V COVID-19 vaccine. the consortium will produce 500 million doses of the vaccine. However, The Sputnik V doses manufactured...
21 KB (1,381 words) - 20:39, 16 May 2024
– Sinopharm BIBP COVID-19 vaccine. 22 December 2020 – Pfizer-BioNTech COVID-19 vaccine. 21 January 2021 – Sputnik V COVID-19 vaccine. February – Oxford–AstraZeneca...
9 KB (403 words) - 20:45, 16 May 2024
the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the...
14 KB (944 words) - 20:36, 16 May 2024
pro-Russian region rejected the vaccines, declaring that it preferred to use the Pfizer–BioNTech or the Sputnik V COVID-19 vaccines, the latter being from Russia...
37 KB (3,121 words) - 20:42, 16 May 2024
COVID-19 vaccine arrived at NAIA around 9 p.m consisting of 193,050 doses via Air Hong Kong. May 12 – The second batch of Sputnik V COVID-19 vaccine (procured)...
162 KB (17,928 words) - 18:58, 12 February 2024
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of...
2 KB (98 words) - 04:31, 28 August 2023
Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against...
31 KB (2,491 words) - 20:36, 16 May 2024
million doses of the Sinopharm BIBP vaccine per month. In January, Morocco approved the following vaccines: Sputnik V, Sinopharm BIBP, and Oxford–AstraZeneca...
20 KB (1,097 words) - 20:37, 16 May 2024
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion...
129 KB (12,608 words) - 17:52, 13 May 2024
Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal...
15 KB (1,034 words) - 20:43, 16 May 2024
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
71 KB (5,359 words) - 07:41, 1 May 2024
The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results...
10 KB (1,003 words) - 16:40, 27 January 2024
Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June...
9 KB (650 words) - 19:24, 9 November 2023
Benbahmad announced that an agreement had been reached to produce Sputnik V COVID-19 vaccine at Saidal's manufacturing plant in Constantine. The Biovac Institute...
110 KB (11,867 words) - 22:35, 9 November 2023